| KC1036 in Combination With PD-1 Antibody and Platinum-based Chemotherapy for First-line Advanced Esophageal Cancer (NCT07481058) | Beijing Konruns Pharmaceutical Co., Ltd. | 2025-12-12 |
| A Study of KC1086 in Patients With Advanced Solid Tumors (NCT07118709) | Beijing Konruns Pharmaceutical Co., Ltd. | 2025-08-01 |
| A Study of KC1036 in Adolescents With Advanced Ewing Sarcoma (NCT06564272) | Beijing Konruns Pharmaceutical Co., Ltd. | 2024-09-27 |
| A Study of KC1036 Versus Investigator's Choice of Chemotherapy in Patients With Advanced Esophageal Cancer (NCT06194734) | Beijing Konruns Pharmaceutical Co., Ltd. | 2024-02-05 |
| A Study of KC1036 in Patients with Advanced Thymic Tumors (NCT05683886) | Beijing Konruns Pharmaceutical Co., Ltd. | 2023-02-22 |
| A Study of Jincaopian Tablets on Chronic Pelvic Pain After Pelvic Inflammatory Disease (NCT05970783) | Beijing Konruns Pharmaceutical Co., Ltd. | 2022-11-08 |
| A Food Effect Study of KC1036 in Healthy Subjects (NCT05265338) | Beijing Konruns Pharmaceutical Co., Ltd. | 2022-03-10 |
| To Evaluate KC1036 in the Patients with Advanced Digestive System Tumors (NCT05260385) | Beijing Konruns Pharmaceutical Co., Ltd. | 2022-01-24 |
| The Effect of Jincaopian Tablets on Chronic Pelvic Pain After Pelvic Inflammatory Disease (NCT05460546) | Beijing Konruns Pharmaceutical Co., Ltd. | 2021-01-19 |
| A Study of KC1036 in Patients with Advanced Solid Tumors (NCT04387916) | Beijing Konruns Pharmaceutical Co., Ltd. | 2020-09-04 |
| A Phase 1 Study of CX1003 (Kanitinib) in Patients with Advanced Solid Tumors (NCT04093466) | Beijing Konruns Pharmaceutical Co., Ltd. | 2020-04-27 |
| Study of CX1106 in Patients With Advanced Head and Neck Squamous Cell Carcinoma (NCT04093115) | Beijing Konruns Pharmaceutical Co., Ltd. | 2019-12-09 |